Sa1112 - Endoscopic Features are Significantly Associated with Histologic Measures of Disease Activity in Patients with Active Eosinophilic Esophagitis: A Post HOC Analysis of a Randomized, Placebo-Controlled, Phase 2 Dupilumab Trial
Ikuo Hirano(Northwestern University), Allen Radin(Regeneron (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Jennifer D. Hamilton(Regeneron (United States)), Margaret H. Collins(Cincinnati Children's Hospital Medical Center), Leda Mannent(Sanofi (France)), Neil M.H. Graham(UK Dementia Research Institute), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Gianluca Pirozzi(Sanofi (United States)), Zhen Chen(Ningbo University), Mirna Chehade(Icahn School of Medicine at Mount Sinai), Alain Schoepfer(University Hospital of Lausanne)
Cited by 1
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k